UPDATE 2-AbbVie sees substantial hit to Botox from pandemic, lowers Humira growth forecast
May 01, 2020 at 11:37 AM EDT
AbbVie Inc on Friday said it expects the coronavirus outbreak to substantially limit sales of Botox and similar aesthetic products that the U.S. drugmaker is set to acquire through its buyout of Allergan Plc.
